Skip to main content

WEST PHARMACEUTICAL SERVICES INC

corporate_fare Company Profile

WEST PHARMACEUTICAL SERVICES INC

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Exchange: NYSESector: Industrial Applications And Services

show_chartPrice Chart

Loading chart...

feed WST - Latest Insights

WST
Apr 23, 2026, 4:12 PM EDT
Filing Type: 10-Q
Importance Score:
8
WST
Apr 23, 2026, 10:56 AM EDT
Source: Reuters
Importance Score:
9
WST
Apr 23, 2026, 7:11 AM EDT
Filing Type: 8-K
Importance Score:
8
WST
Apr 23, 2026, 6:22 AM EDT
Source: dpa-AFX
Importance Score:
8
WST
Apr 23, 2026, 6:03 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
WST
Mar 12, 2026, 8:31 AM EDT
Filing Type: DEF 14A
Importance Score:
7
WST
Mar 09, 2026, 4:33 PM EDT
Filing Type: 8-K
Importance Score:
7
WST
Feb 17, 2026, 4:28 PM EST
Filing Type: 10-K
Importance Score:
8
WST
Feb 12, 2026, 7:21 AM EST
Filing Type: 8-K
Importance Score:
7